A U.S. Patent for the “Removal of Fragments from a Sample Containing a Target Protein Using Activated Carbon” was awarded to Merck KGaAon December 31st, 2019. The present invention is a method of reducing the amount of antibody fragments in a sample comprising an antibody to be purified, the method comprising the steps of: (a) providing a sample comprising an antibody and antibody fragments, wherein the fragments are in an amount equal to or greater than at least 0.2% of the amount of the antibody, (b) contacting the sample with activated carbon, wherein the activated carbon binds the antibody fragments… Learn More